Quarterly report · Q2
4360.TEDINET S100PEE3
Period2022-04-01 → 2022-09-30
Filed2022-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks11 of 11 passed
Key figures · 30
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥5.1bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥10.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Operating income | ¥322m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥474m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥881m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥520m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥383m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥712m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥383m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥14.2bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥13.6bn | at 2022-03-31 | Cons. | Assets |
| Total liabilities | ¥3.6bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥3.3bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥10.6bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥10.3bn | at 2022-03-31 | Cons. | Net assets |
| Cash and deposits | ¥2.6bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.0bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.6bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.0bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥372m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥714m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥300m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥422m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥51m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥200m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥48.32 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥33.3 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥90.52 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 74.5% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.8% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 12
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E36769-000Fine Chemical Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.7bn |
| jpcrp040300-q2r_E36769-000Fine Chemical Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.7bn |
| jpcrp040300-q2r_E36769-000Fine Chemical Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥314m |
| jpcrp040300-q2r_E36769-000Flame Retardants Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥2.8bn |
| jpcrp040300-q2r_E36769-000Flame Retardants Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥2.8bn |
| jpcrp040300-q2r_E36769-000Flame Retardants Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥670m |
| jpcrp040300-q2r_E36769-000Health Support Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥605m |
| jpcrp040300-q2r_E36769-000Health Support Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥605m |
| jpcrp040300-q2r_E36769-000Health Support Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥21m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥5.1bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥5.1bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥1.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 355
| Item | Context | Value | Unit |
|---|---|---|---|
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 11 of 11 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |